journal article·2019-10

The role of magnesium ions in bone regeneration involves the canonical Wnt signaling pathway

Chu-Chih Hung, Amy Chaya, Kai Liu, Konstantinos Verdelis, Charles Sfeir

Acta Biomaterialia· Volume 98
Publisher page

Abstract

Magnesium (Mg)-based implants have become of interest to both academia and the medical industry. The attraction largely is due to Mg's biodegradability and ability to enhance bone healing and formation. However, the underlying mechanism of how Mg regulates osteogenesis is still unclear. Based on our previous in vivo and molecular signaling work demonstrating the osteogenic effect of Mg, the current study aims to extend this work at the molecular level especially that we also observed and quantified mineral deposits in the bone marrow space in a rabbit ulna fracture model with Mg plates and screws. Histological analysis and quantitative results of micro-CT showed mineralized deposition and a significant increase in bone volume at 8 weeks and 16 weeks post-operative. These in vivo results led us to focus on studying the effect of Mg2+ on human bone marrow stromal cells (hBMSCs). The data presented in this manuscript demonstrate the activation of the canonical Wnt signaling pathway in hBMSCs when treated with 10 mM Mg2+. With additional Mg2+ present, the protein expression of active β-catenin was significantly increased to a level similar to that of the positive control. Immunocytochemistry and the increased expression of LEF1 and Dkk1, downstream target genes that are controlled directly by active β-catenin, demonstrated the protein translocation and the activation of transcription. Taken together, these data suggest that Mg2+ induces an osteogenic effect in the bone marrow space by activating the canonical Wnt signaling pathway, which in turn causes BMSCs to differentiate toward the osteoblast lineage. STATEMENT OF SIGNIFICANCE: Magnesium (Mg)-based alloys are being studied to be used in the field of implantable medical devices due to its natural biodegradability and the potential ability to promote bone regeneration. Despite many in vivo studies that demonstrated an increased new bone growth by implanting Mg-based devices, the underlying mechanism of this effect is still unclear. In order to safely use Mg-based implants on human and better control the osteogenic effect, it is necessary to understand the corresponding cellular response in the targeted area. The present study provides the rationale to study Mg ions on bone marrow stromal cells and shows the activation of canonical Wnt signaling pathway that promotes osteogenesis by in vivo and in vitro approaches.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Theology and Canon Law Studies · Hydrogen Storage and Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Magnesium and its alloys as orthopedic biomaterials: a review10.1016/j.biomaterials.2005.10.003 ↗
2. In vivo corrosion of four magnesium alloys and the associated bone response10.1016/j.biomaterials.2004.09.049 ↗
3. Magnesium-based bone implants: immunohistochemical analysis of peri-implant osteogenesis by evaluation of osteopontin and osteocalcin expression10.1002/jbm.a.34828 ↗
4. In vivo study of magnesium plate and screw degradation and bone fracture healing10.1016/j.actbio.2015.02.010 ↗
5. Biodegradable metals10.1016/j.mser.2014.01.001 ↗
6. Magnesium alloys for temporary implants in osteosynthesis: in vivo studies of their degradation and interaction with bone10.1016/j.actbio.2011.11.008 ↗
7. Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats10.1038/nm.4162 ↗
8. Magnesium ion stimulation of bone marrow stromal cells enhances osteogenic activity, simulating the effect of magnesium alloy degradation10.1016/j.actbio.2014.02.002 ↗
9. Wnt signal transduction pathways10.4161/org.4.2.5851 ↗
10. WNT signaling in bone homeostasis and disease: from human mutations to treatments10.1038/nm.3074 ↗
11. Roles of Wnt signaling in bone formation and resorption10.1016/j.jdsr.2007.11.002 ↗
12. Regulation of bone mass by Wnt signaling10.1172/JCI28551 ↗
13. Wnt signaling in bone, Clinical pediatric endocrinology: case reports and clinical investigations: official journal of the Japanese Society for Pediatric
14. Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells10.1016/j.bone.2005.01.007 ↗
15. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo10.1359/jbmr.060316 ↗
16. Wnt/beta-catenin signaling: components, mechanisms, and diseases10.1016/j.devcel.2009.06.016 ↗
17. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling10.1074/jbc.M413274200 ↗
18. H. Aberle, A. Bauer, J. Stappert, A. Kispert, R.J.T.E.j. Kemler, β‐catenin is a target for the ubiquitin–proteasome pathway, 16(13), 1997, 3797–3804.10.1093/emboj/16.13.3797 ↗
19. Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a10.1111/j.1365-2443.2007.01068.x ↗
20. Wnt proteins are lipid-modified and can act as stem cell growth factors10.1038/nature01611 ↗
21. LEF1 and B9L shield beta-catenin from inactivation by Axin, desensitizing colorectal cancer cells to tankyrase inhibitors10.1158/0008-5472.CAN-13-2682 ↗
22. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter10.1074/jbc.M107977200 ↗
23. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer10.1038/ng0501-53 ↗
24. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer10.1038/sj.onc.1208303 ↗
25. FGF-20 and DKK1 are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development10.1038/sj.emboj.7600460 ↗
26. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP610.1016/S0960-9822(01)00290-1 ↗
27. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins10.1038/35077108 ↗
28. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow10.1038/35083081 ↗
29. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway10.1038/sj.onc.1207892 ↗
30. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement10.1080/14653240600855905 ↗
31. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces10.1073/pnas.2434367100 ↗
32. Bone tissue reconstruction using titanium fiber mesh combined with rat bone marrow stromal cells10.1016/S0142-9612(02)00537-9 ↗
33. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro10.1002/jcb.10174 ↗
34. Cytoskeletal organization of human mesenchymal stem cells (MSC) changes during their osteogenic differentiation10.1002/jcb.20234 ↗
35. Review of signaling pathways governing msc osteogenic and adipogenic differentiation10.1155/2013/684736 ↗
36. Biodegradable magnesium scaffolds: part II: peri-implant bone remodeling10.1002/jbm.a.31293 ↗
37. Mechanical stimulation alters tissue differentiation and molecular expression during bone healing10.1002/jor.20863 ↗
38. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing10.1371/journal.pmed.0040249 ↗
39. Beta-catenin-dependent Wnt signaling in mandibular bone regeneration10.2106/JBJS.G.01136 ↗
40. Wnt signaling during fracture repair10.1007/s11914-009-0012-5 ↗
41. Role of Wnt signaling in fracture healing10.5483/BMBRep.2014.47.12.193 ↗
42. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes10.1016/j.devcel.2005.02.013 ↗
43. Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms10.1074/jbc.M501080200 ↗
44. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor10.1083/jcb.200201089 ↗
45. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis10.1016/j.devcel.2005.03.016 ↗
46. Sequential roles of Hedgehog and Wnt signaling in osteoblast development10.1242/dev.01564 ↗
47. WNT and beta-catenin signalling: diseases and therapies10.1038/nrg1427 ↗
48. Wnt/beta-catenin signaling and disease10.1016/j.cell.2012.05.012 ↗
49. Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass10.1074/jbc.M110.165100 ↗